RHYTHM PHARMACEUTICALS, INC.: net_income
| Value | {"amount": -184678000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | RHYTHM PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:59:00.142100+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/af14724c-fc71-4c2a-aae0-f0a83dacf2ff
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-24-002181Retrieved: 2026-08-19T16:59:00.142100+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001649904/net-income/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/af14724c-fc71-4c2a-aae0-f0a83dacf2ff
History
- supersedes {"amount": -184678, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"} (evidence 0001628280-26-028375)